应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
03759 康龙化成
提前休市 12-24 12:08:24
20.740
-0.300
-1.43%
最高
21.180
最低
20.280
成交量
698.69万
今开
21.180
昨收
21.040
日振幅
4.28%
总市值
367.31亿
流通市值
61.03亿
总股本
17.71亿
成交额
1.44亿
换手率
2.37%
流通股本
2.94亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
股市必读:12月23日康龙化成现1笔大宗交易 机构净买入4282.5万元
证券之星 · 01:24
股市必读:12月23日康龙化成现1笔大宗交易 机构净买入4282.5万元
股市必读:12月22日康龙化成现1笔大宗交易 机构净买入4312.5万元
证券之星 · 12-23 01:13
股市必读:12月22日康龙化成现1笔大宗交易 机构净买入4312.5万元
每日卖空追踪 | 康龙化成 12月22日卖空量成交9.12万股,卖空比例为1.6%
市场透视 · 12-22 16:30
每日卖空追踪 | 康龙化成 12月22日卖空量成交9.12万股,卖空比例为1.6%
港股异动 | CRO概念股承压走低 康龙化成(03759)跌超4% 昭衍新药(06127)跌超3%
智通财经 · 12-22 15:24
港股异动 | CRO概念股承压走低 康龙化成(03759)跌超4% 昭衍新药(06127)跌超3%
医药外包概念股逆市受压 康龙化成(03759)跌4.14% 机构指美生物安全法案对华CXO企业经营影响有限
金吾财讯 · 12-22 14:06
医药外包概念股逆市受压 康龙化成(03759)跌4.14% 机构指美生物安全法案对华CXO企业经营影响有限
6家CRO,赚了!
药通社 · 12-20
6家CRO,赚了!
智通港股解盘 | 海南自贸港封关意义重大 无人驾驶利好密集催化
智通财经 · 12-19
智通港股解盘 | 海南自贸港封关意义重大 无人驾驶利好密集催化
每日卖空追踪 | 康龙化成 12月19日卖空量成交23.16万股,卖空比例为5.41%
市场透视 · 12-19
每日卖空追踪 | 康龙化成 12月19日卖空量成交23.16万股,卖空比例为5.41%
医药外包概念普遍走高 药明生物(02269)涨6.11% 机构看好看好CXO在业绩和估值端迎来双重修复
金吾财讯 · 12-19
医药外包概念普遍走高 药明生物(02269)涨6.11% 机构看好看好CXO在业绩和估值端迎来双重修复
康龙化成盘中异动 大幅上涨5.07%报22.400港元
市场透视 · 12-19
康龙化成盘中异动 大幅上涨5.07%报22.400港元
康龙化成:2025年第一次临时股东大会决议公告
证券日报 · 12-18
康龙化成:2025年第一次临时股东大会决议公告
康龙化成(03759):曾劲峰获委任为独立非执行董事
智通财经 · 12-18
康龙化成(03759):曾劲峰获委任为独立非执行董事
每日卖空追踪 | 康龙化成 12月17日卖空量成交11.25万股,卖空比例为4.46%
市场透视 · 12-17
每日卖空追踪 | 康龙化成 12月17日卖空量成交11.25万股,卖空比例为4.46%
英伟达连续布局13家企业,AI制药3个方向梳理(附列表)
投研大叔 · 12-13
英伟达连续布局13家企业,AI制药3个方向梳理(附列表)
康龙化成2025年三季报:新签订单加速增长,一体化平台与收购协同打开成长空间
极简财报 · 12-13
康龙化成2025年三季报:新签订单加速增长,一体化平台与收购协同打开成长空间
康龙化成(300759)披露持股5%以上股东持股变动触及1%整数倍公告,12月12日股价上涨2.96%
证券之星 · 12-12
康龙化成(300759)披露持股5%以上股东持股变动触及1%整数倍公告,12月12日股价上涨2.96%
每日卖空追踪 | 康龙化成 12月12日卖空量成交18.2万股,卖空比例为3.78%
市场透视 · 12-12
每日卖空追踪 | 康龙化成 12月12日卖空量成交18.2万股,卖空比例为3.78%
CRO概念股普涨 昭衍新药涨5.94% 实验猴价格递增侧面印证CRO行业订单回暖
金吾资讯 · 12-11
CRO概念股普涨 昭衍新药涨5.94% 实验猴价格递增侧面印证CRO行业订单回暖
国开证券:医药行业估值降至10年来的底部水平 关注配置价值
国开证券 · 12-11
国开证券:医药行业估值降至10年来的底部水平 关注配置价值
每日卖空追踪 | 康龙化成 12月10日卖空量成交8.89万股,卖空比例为4.62%
市场透视 · 12-10
每日卖空追踪 | 康龙化成 12月10日卖空量成交8.89万股,卖空比例为4.62%
加载更多
公司概况
公司名称:
康龙化成
所属市场:
SEHK
上市日期:
--
主营业务:
康龙化成(北京)新药技术股份有限公司是一家主要从事医药研发的中国公司。该公司运营五个分部。实验室服务分部主要包括实验室化学和生物科学服务,服务项目涵盖小分子化学药、寡核苷酸、多肽、抗体、抗体偶联药物和细胞与基因治疗产品等。化学和制剂工艺开发及生产服务分部包括原料药工艺开发及生产以及预制剂、制剂开发。临床研究服务分部包括国外临床研究服务和国内临床研究服务。大分子和细胞与基因治疗服务分部包括大分子药物发现及开发与生产服务和细胞与基因治疗实验室及基因治疗药物开发与生产服务。该公司还通过其他分部开展业务。
发行价格:
--
{"stockData":{"symbol":"03759","market":"HK","secType":"STK","nameCN":"康龙化成","latestPrice":20.74,"timestamp":1766549304006,"preClose":21.04,"halted":0,"volume":6986857,"delay":0,"floatShares":294273825,"shares":1771000000,"eps":1.1241320263724646,"marketStatus":"提前休市","change":-0.3,"latestTime":"12-24 12:08:24","open":21.18,"high":21.18,"low":20.28,"amount":143826557,"amplitude":0.042776,"askPrice":20.74,"askSize":9500,"bidPrice":20.7,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.9497379135275503,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766971800000},"marketStatusCode":6,"adr":0,"listingDate":1574870400000,"exchange":"SEHK","adjPreClose":21.04,"dividendRate":0.01055,"openAndCloseTimeList":[[1766539800000,1766548800000]],"volumeRatio":4.063685,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"300759","market":"SZ","secType":"STK","nameCN":"康龙化成","latestPrice":28.91,"timestamp":1766559600000,"preClose":28.81,"halted":0,"volume":13493200,"delay":0,"premium":"-35.33"}},"requestUrl":"/m/hq/s/03759","defaultTab":"news","newsList":[{"id":"2593414015","title":"股市必读:12月23日康龙化成现1笔大宗交易 机构净买入4282.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593414015","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593414015?lang=zh_cn&edition=full","pubTime":"2025-12-24 01:24","pubTimestamp":1766510654,"startTime":"0","endTime":"0","summary":"截至2025年12月23日收盘,康龙化成报收于28.81元,下跌0.69%,换手率0.96%,成交量13.65万手,成交额3.94亿元。当日关注点来自交易信息汇总:12月23日主力资金净流出3242.19万元,散户资金净流入2821.38万元。大宗交易12月23日康龙化成发生1笔大宗交易,机构净买入4282.5万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400000662.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","03759","BK0216","300759","BK1576"],"gpt_icon":0},{"id":"2593756431","title":"股市必读:12月22日康龙化成现1笔大宗交易 机构净买入4312.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593756431","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593756431?lang=zh_cn&edition=full","pubTime":"2025-12-23 01:13","pubTimestamp":1766423595,"startTime":"0","endTime":"0","summary":"截至2025年12月22日收盘,康龙化成报收于29.01元,下跌1.46%,换手率1.43%,成交量20.36万手,成交额5.92亿元。当日关注点来自交易信息汇总:12月22日主力资金净流入1712.12万元,显示主力对康龙化成的积极介入。来自交易信息汇总:同日发生1笔大宗交易,机构净买入4312.5万元,反映机构投资者的显著增持行为。来自交易信息汇总:游资资金净流出3629.05万元,表明短线资金在当日选择离场。大宗交易12月22日康龙化成现1笔大宗交易,机构净买入4312.5万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300000625.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","BK0216","300759","BK1576","03759"],"gpt_icon":0},{"id":"2593458170","title":"每日卖空追踪 | 康龙化成 12月22日卖空量成交9.12万股,卖空比例为1.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593458170","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593458170?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:30","pubTimestamp":1766392235,"startTime":"0","endTime":"0","summary":"康龙化成北京时间12月22日,跌3.87%,卖空量成交9.12万股,较上一交易日减少79.27%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163650a4699800&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163650a4699800&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","03759"],"gpt_icon":0},{"id":"2593710420","title":"港股异动 | CRO概念股承压走低 康龙化成(03759)跌超4% 昭衍新药(06127)跌超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593710420","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593710420?lang=zh_cn&edition=full","pubTime":"2025-12-22 15:24","pubTimestamp":1766388287,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,CRO概念股承压走低,截至发稿,康龙化成跌4.32%,报21.24港元;昭衍新药跌3.29%,报21.16港元;凯莱英跌2.31%,报78.15港元;维亚生物跌1.98%,报1.98港元。信达证券指,过去两年《生物安全法案》是压制CXO板块估值的重要原因,和最初版本相比,最终落地的版本没有点名具体企业,整体相对温和。虑到美联储已经进入降息通道,全球生物医药投融资有望边际改善,随着法案落地,CXO板块有望迎来业绩和估值的双重修复。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384340.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03759","BK0216","BK1191","06127","300759","01873","BK1576","06821","603127","BK1141"],"gpt_icon":0},{"id":"2593657109","title":"医药外包概念股逆市受压 康龙化成(03759)跌4.14% 机构指美生物安全法案对华CXO企业经营影响有限","url":"https://stock-news.laohu8.com/highlight/detail?id=2593657109","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593657109?lang=zh_cn&edition=full","pubTime":"2025-12-22 14:06","pubTimestamp":1766383579,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药外包概念股逆市受压,截至发稿,康龙化成 跌4.14%,药明生物跌3.75%,药明康德跌2.89%,昭衍新药跌2.67%,泰格医药跌2.07%,金斯瑞生物科技跌1.36%。招银国际表示,MSCI中国医疗指数2025年初至今累计上涨51.9%,跑赢MSCI中国指数24.3%。近期,医药板块有所回调。政策端方面,《生物安全法案》虽已签署生效,但鉴于其未波及Medicaid和Medicare的采购且对关联方定义明确,以及中国CXO美国行政机构收入占比较小,该机构预计该法案对中国CXO企业实质经营影响有限。","market":"us","thumbnail":"https://static.szfiu.com/news/20250110/ZDlhMzNiODA0MWQ5OWM0NDQ5YzUxMTZmZWRlMTczNjQ3MzM4NzkwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/ZDlhMzNiODA0MWQ5OWM0NDQ5YzUxMTZmZWRlMTczNjQ3MzM4NzkwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1972004","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516902.SGD","LU0516422440.USD","09939","BK1576","LU0516423091.SGD","LU0327786744.USD","LU1242518931.SGD","LU0708995583.HKD","BK1574","300759","LU2125910500.SGD","03347","02359","LU0819121731.USD","LU0823426308.USD","LU1720050803.USD","LU2039709279.SGD","LU0417516738.SGD","LU0320764599.SGD","HK0000320223.HKD","HK0000306685.HKD","LU0326950275.SGD","01548","LU0572944931.SGD","BK1141","LU0140636845.USD","HK0000320264.USD","BK1589","BK1610","BK1161","CXO","LU1880383366.USD","LU0359202008.SGD","LU0348735423.USD","LU0051755006.USD","LU1046422090.SGD","HK0000306701.USD","06127","SG9999002463.SGD","BK0216","LU3063872942.SGD","159938","LU0456846285.SGD","03759","02269","LU0359201612.USD","LU0516423174.USD","LU0348825331.USD","SG9999002562.SGD","BK1583"],"gpt_icon":0},{"id":"2593055142","title":"6家CRO,赚了!","url":"https://stock-news.laohu8.com/highlight/detail?id=2593055142","media":"药通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593055142?lang=zh_cn&edition=full","pubTime":"2025-12-20 12:42","pubTimestamp":1766205731,"startTime":"0","endTime":"0","summary":"药明康德作为CRO行业大哥,对于资源端的布局自然走在前列,其在2020年收购广东泰盛,目前存栏2万余只,强化了一体化供应链。昭衍新药是国内自有实验猴资源多的CRO之一,据悉,2022年其收购广西玮美和云南英茂,并结合自建玉林农场,饲养能力1.5万只,目前自有猴只总量已超2万只。此番实验猴涨价,多家CRO重金求猴,而这6家CRO凭借自有布局直接获益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220125758a6b99c01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220125758a6b99c01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03759","06127","BK1576","BK1141"],"gpt_icon":0},{"id":"2592162940","title":"智通港股解盘 | 海南自贸港封关意义重大 无人驾驶利好密集催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2592162940","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592162940?lang=zh_cn&edition=full","pubTime":"2025-12-19 20:58","pubTimestamp":1766149121,"startTime":"0","endTime":"0","summary":"海南自由贸易港昨天正式启动全岛封关,8个对外开放口岸及10个“二线口岸”监管设施全部启用。标志着3万多平方公里的海南岛正式成为海关监管特殊区域,中国对外开放迎来具有里程碑意义的标志性举措。回购的H股股份将作为库存股持有,并在完成回购并披露回购结果公告后三年内完成转让或注销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383905.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01801","BK1179","06821","LU0516423091.SGD","01318","02431","03759","01880","601995","BK1163","02039","02050","00699","BK1564","LU1719994722.HKD","LU2328871848.SGD","LU0307460666.USD","03908","BK1539","LU0819121731.USD","LU1880383366.USD","LU2039709279.SGD","01057","LU0417516902.SGD","01316","BK1500","LU0181495838.USD","06160","LU0348735423.USD","01999","02498","LU1794554557.SGD","02269","09868","BK1183","LU1969619763.USD","BK1589","LU0455707207.USD","BK1583","LU0348766576.USD","BK1224","LU1580142542.USD","09863","02533","SG9999002463.SGD","BK1191","BK1521","LU0593848301.USD"],"gpt_icon":1},{"id":"2592427192","title":"每日卖空追踪 | 康龙化成 12月19日卖空量成交23.16万股,卖空比例为5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592427192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592427192?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:30","pubTimestamp":1766133034,"startTime":"0","endTime":"0","summary":"康龙化成北京时间12月19日,涨4.13%,卖空量成交23.16万股,较上一交易日增加56.91%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163549a6b646ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163549a6b646ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","03759"],"gpt_icon":0},{"id":"2592139047","title":"医药外包概念普遍走高 药明生物(02269)涨6.11% 机构看好看好CXO在业绩和估值端迎来双重修复","url":"https://stock-news.laohu8.com/highlight/detail?id=2592139047","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592139047?lang=zh_cn&edition=full","pubTime":"2025-12-19 10:26","pubTimestamp":1766111188,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药外包概念普遍走高,药明生物 涨6.11%,凯莱英升5.52%,康龙化成升4.69%,泰格医药升3.8%,维亚生物升3.72%,药明康德涨3.32%。世纪证券此前研报指出,本周NDAA法案落地,地缘风险趋于缓和。CXO业绩和新增订单开始好转,本周市场开始关注临床前安评试验资产食蟹猴。该机构认为CXO作为创新药产业链上游,行业经历过完整周期,有望受益于国产创新药竞争力提升带来的景气度回升,看好CXO在业绩和估值端迎来双重修复。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250110/MjA1YmE2ZTUwNGJlNDY3ODMxMDE0ODI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MjA1YmE2ZTUwNGJlNDY3ODMxMDE0ODI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"66afc1ba6d0078bbc724c4259409298b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971871","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU3063872942.SGD","LU0348825331.USD","LU1720050803.USD","CXO","LU0819121731.USD","BK1583","BK1161","BK1191","LU2242644610.SGD","BK1576","LU0979878070.USD","LU0140636845.USD","LU0516422440.USD","LU0708995583.HKD","03759","LU0320764599.SGD","SG9999002463.SGD","LU2045819591.USD","BK1589","LU1880383366.USD","BK1521","02269","02359","LU0516423091.SGD","LU0039217434.USD","LU0043850808.USD","LU1242518931.SGD","LU0348735423.USD","LU0417516902.SGD","09939","LU0516422366.SGD","LU0359201612.USD","LU0456827905.SGD","LU0516422952.EUR","LU0052750758.USD","LU0516423174.USD","LU0051755006.USD","IE00B0JY6N72.USD","LU0181495838.USD","BK1610","LU1046422090.SGD","LU2125910500.SGD","SG9999002562.SGD","LU1794554557.SGD","01873","06821","159938","BK1574","LU0823426480.USD","03347"],"gpt_icon":0},{"id":"2592132328","title":"康龙化成盘中异动 大幅上涨5.07%报22.400港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592132328","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592132328?lang=zh_cn&edition=full","pubTime":"2025-12-19 10:16","pubTimestamp":1766110573,"startTime":"0","endTime":"0","summary":"2025年12月19日早盘10时16分,康龙化成股票出现异动,股价急速拉升5.07%。截至发稿,该股报22.400港元/股,成交量183.26万股,换手率0.62%,振幅4.69%。资金方面,该股资金流入1988.68万港元,流出1625.33万港元。康龙化成股票所在的药品行业中,整体涨幅为0.55%。其相关个股中,凯莱英、三生制药、康龙化成涨幅较大,振幅较大的相关个股有三生制药、凯莱英、四环医药,振幅分别为7.17%、5.11%、4.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121910161397a07a65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121910161397a07a65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03759","BK1576","BK1141"],"gpt_icon":0},{"id":"2592909036","title":"康龙化成:2025年第一次临时股东大会决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2592909036","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592909036?lang=zh_cn&edition=full","pubTime":"2025-12-18 21:42","pubTimestamp":1766065326,"startTime":"0","endTime":"0","summary":"证券日报网讯12月18日晚间,康龙化成发布公告称,公司2025年第一次临时股东大会审议通过《关于补选公司第三届董事会独立非执行董事的议案》等多项议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512183595740121.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["03759","BK1141","BK1576","300759","BK0216"],"gpt_icon":0},{"id":"2592139905","title":"康龙化成(03759):曾劲峰获委任为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2592139905","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592139905?lang=zh_cn&edition=full","pubTime":"2025-12-18 20:45","pubTimestamp":1766061924,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康龙化成(03759)发布公告,由于相关决议案已于临时股东大会上正式通过,曾劲峰教授已获委任为第三届董事会独立非执行董事,自2025年12月18日起生效。此外,曾坤鸿先生已离任独立非执行董事、董事会审计委员会委员、董事会薪酬及考核委员会委员、董事会提名委员会委员,自曾劲峰教授于2025年12月18日获委任为独立非执行董事时生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383336.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","BK1141","03759","BK1576","300759"],"gpt_icon":0},{"id":"2592941695","title":"每日卖空追踪 | 康龙化成 12月17日卖空量成交11.25万股,卖空比例为4.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592941695","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592941695?lang=zh_cn&edition=full","pubTime":"2025-12-17 16:30","pubTimestamp":1765960234,"startTime":"0","endTime":"0","summary":"康龙化成北京时间12月17日,涨1.15%,卖空量成交11.25万股,较上一交易日减少49.62%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163537a4561454&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163537a4561454&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03759","BK1576","BK1141"],"gpt_icon":0},{"id":"2591632904","title":"英伟达连续布局13家企业,AI制药3个方向梳理(附列表)","url":"https://stock-news.laohu8.com/highlight/detail?id=2591632904","media":"投研大叔","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591632904?lang=zh_cn&edition=full","pubTime":"2025-12-13 19:40","pubTimestamp":1765626014,"startTime":"0","endTime":"0","summary":"今天介绍下AI制药,英伟达在过去2年投资13家AI药企,推出BioNeMo生物分子AI框架已经覆盖上百家药企,英硅智能ISM001-055进入临床III期,成为首个跨越临床II期的AI药物,从之前的布局到如今逐渐突破,商业价值正在逐渐被验证。从大叔个人来看,还有一些罕见病,由于患者少,研发不划算,而AI能快速低成本设计药物,让更多罕见病有药可治。近期热门文章HW组建医疗卫生军团,AI医疗爆发!","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251213194757a4470c58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251213194757a4470c58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0308772762.SGD","LU1914381329.SGD","LU0157215616.USD","LU2065171311.SGD","06127","SGXZ81514606.USD","LU2860962120.EUR","NVDA","NVIW.SI","LU0320765059.SGD","LU0158827948.USD","LU0444973449.USD","NVD2.UK","NVDY","2NVD.UK","LU0096362180.USD","LU1280957306.USD","LU2505996509.AUD","LU2249611893.SGD","IE000YTNTUN2.SGD","NVDX","IE0034235188.USD","01093","LU2191332357.HKD","IE00BDCRKT87.USD","LU2463028550.USD","SNVD.UK","SG9999004303.SGD","LU2237438978.USD","NVD3.UK","LU1988902786.USD","IE000ITXATA3.USD","02359","IE00BJJMRY28.SGD","NVDS.UK","NVD","LU2473716301.USD","LU1839511570.USD","LU2602419157.SGD","NVDD","02228","LU1145028129.USD","LU1496350171.SGD","LU0719512351.SGD","NVDU","03759","LU2505996681.GBP","LU0274383776.USD","3NVD.UK","LU2592432038.USD","LU1642822529.SGD","06821","LU2420271590.USD","NVDS","02196","LU2089284900.SGD"],"gpt_icon":1},{"id":"2591655597","title":"康龙化成2025年三季报:新签订单加速增长,一体化平台与收购协同打开成长空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2591655597","media":"极简财报","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591655597?lang=zh_cn&edition=full","pubTime":"2025-12-13 06:33","pubTimestamp":1765578803,"startTime":"0","endTime":"0","summary":"尽管前三季度归母净利润同比下滑,但这主要受2024年同期处置子公司股权产生大额投资收益带来的高基数影响。前三季度该板块新签订单同比增长超过12%,增速较上半年进一步加快。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251213063731a445ad30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251213063731a445ad30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","03759"],"gpt_icon":0},{"id":"2590572051","title":"康龙化成(300759)披露持股5%以上股东持股变动触及1%整数倍公告,12月12日股价上涨2.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590572051","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590572051?lang=zh_cn&edition=full","pubTime":"2025-12-12 17:52","pubTimestamp":1765533155,"startTime":"0","endTime":"0","summary":"截至2025年12月12日收盘,康龙化成报收于29.91元,较前一交易日上涨2.96%,最新总市值为531.86亿元。公司近日发布公告称,持股5%以上股东深圳市信中康成投资合伙企业及其一致行动人深圳市信中龙成投资合伙企业因减持股份,导致持股比例变动触及1%整数倍。2025年7月10日至12月10日期间,两股东合计减持17,782,019股,占公司总股本的1.00%。其中信中康成减持15,553,519股,信中龙成减持2,228,500股。减持后,两股东合计持股比例由15.00%降至14.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200028653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03759","300759","BK1576","BK1141","BK0216"],"gpt_icon":0},{"id":"2591868766","title":"每日卖空追踪 | 康龙化成 12月12日卖空量成交18.2万股,卖空比例为3.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591868766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591868766?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:30","pubTimestamp":1765528232,"startTime":"0","endTime":"0","summary":"康龙化成北京时间12月12日,涨5.07%,卖空量成交18.2万股,较上一交易日增加33.14%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212165629a4446d41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212165629a4446d41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","03759"],"gpt_icon":0},{"id":"2590934566","title":"CRO概念股普涨 昭衍新药涨5.94% 实验猴价格递增侧面印证CRO行业订单回暖","url":"https://stock-news.laohu8.com/highlight/detail?id=2590934566","media":"金吾资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590934566?lang=zh_cn&edition=full","pubTime":"2025-12-11 10:01","pubTimestamp":1765418460,"startTime":"0","endTime":"0","summary":"金吾财讯 | CRO概念股普涨,截至发稿,昭衍新药 涨5.94%,药明康德涨3.26%,药明生物涨2.44%,康龙化成涨1.87%,泰格医药涨1.71%,金斯瑞生物科技涨1.51%。消息面上,北京商报报道称,目前3—5岁左右的食蟹猴价格已涨至14万元一只,且年内已出现供不应求的局面。据悉,实验猴一般是猕猴、食蟹猴等猕猴属动物,是医学研究不可缺少的重要实验动物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211100147a730f084&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211100147a730f084&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","03347","01548","BK1576","03759","02269","06127"],"gpt_icon":0},{"id":"2590566931","title":"国开证券:医药行业估值降至10年来的底部水平 关注配置价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2590566931","media":"国开证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590566931?lang=zh_cn&edition=full","pubTime":"2025-12-11 08:04","pubTimestamp":1765411491,"startTime":"0","endTime":"0","summary":"国开证券认为,2025年医药行业走出了结构性行情,目前行业估值降至10年来的底部水平,同时行业基金持仓比也降至近10年的底部,我们建议关注行业的配置价值。方向一:创新药作为医药行业的硬科技代表,经过近10年的快速发展,已经取得了初步的成果。AI+医疗是人工智能最早落地的应用领域之一,应用场景丰富,以大模型为代表的AI技术进步有望助推医疗服务效率和质量提升,同时政策支持力度较高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211080417a730b555&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211080417a730b555&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","03759","BK1576"],"gpt_icon":0},{"id":"2590669655","title":"每日卖空追踪 | 康龙化成 12月10日卖空量成交8.89万股,卖空比例为4.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590669655","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590669655?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:30","pubTimestamp":1765355434,"startTime":"0","endTime":"0","summary":"康龙化成北京时间12月10日,涨0.56%,卖空量成交8.89万股,较上一交易日减少77.99%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210163737a43fa060&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210163737a43fa060&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","03759"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pharmaron.com","stockEarnings":[{"period":"1week","weight":0.0077},{"period":"1month","weight":0.0154},{"period":"3month","weight":-0.212},{"period":"6month","weight":0.3684},{"period":"1year","weight":0.5272},{"period":"ytd","weight":0.5119}],"compareEarnings":[{"period":"1week","weight":0.0213},{"period":"1month","weight":0.022},{"period":"3month","weight":-0.0281},{"period":"6month","weight":0.0596},{"period":"1year","weight":0.2963},{"period":"ytd","weight":0.2849}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康龙化成(北京)新药技术股份有限公司是一家主要从事医药研发的中国公司。该公司运营五个分部。实验室服务分部主要包括实验室化学和生物科学服务,服务项目涵盖小分子化学药、寡核苷酸、多肽、抗体、抗体偶联药物和细胞与基因治疗产品等。化学和制剂工艺开发及生产服务分部包括原料药工艺开发及生产以及预制剂、制剂开发。临床研究服务分部包括国外临床研究服务和国内临床研究服务。大分子和细胞与基因治疗服务分部包括大分子药物发现及开发与生产服务和细胞与基因治疗实验室及基因治疗药物开发与生产服务。该公司还通过其他分部开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.032608},{"month":2,"riseRate":0.5,"avgChangeRate":-0.032667},{"month":3,"riseRate":0.5,"avgChangeRate":-0.037718},{"month":4,"riseRate":0.833333,"avgChangeRate":0.041315},{"month":5,"riseRate":0.666667,"avgChangeRate":0.02009},{"month":6,"riseRate":0.666667,"avgChangeRate":0.075892},{"month":7,"riseRate":0.666667,"avgChangeRate":0.081227},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.032342},{"month":9,"riseRate":0.666667,"avgChangeRate":0.134004},{"month":10,"riseRate":0.5,"avgChangeRate":-0.053116},{"month":11,"riseRate":0.333333,"avgChangeRate":0.03614},{"month":12,"riseRate":0.571429,"avgChangeRate":0.035266}],"exchange":"SEHK","name":"康龙化成","nameEN":"PHARMARON"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康龙化成(03759)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康龙化成(03759)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康龙化成,03759,康龙化成股票,康龙化成股票老虎,康龙化成股票老虎国际,康龙化成行情,康龙化成股票行情,康龙化成股价,康龙化成股市,康龙化成股票价格,康龙化成股票交易,康龙化成股票购买,康龙化成股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康龙化成(03759)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康龙化成(03759)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}